QQ客服 官方微博 反馈留言

	MiR-100 Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion and Enhances Chemosensitivity by Targeting IGFIR
	Liu Yang[1]; Zhu Shu-Tao[2]; Wang Xiao[3]; Deng Jun[4]; Li Wei-Hua[5]; Zhang Peng[6]; Liu Bing-Shan[7]
刊名	TECHNOLOGY IN CANCER RESEARCH & TREATMENT
	2016
卷号	15期号:5页码:NP40-NP48
关键词	miR-100 osteosarcoma IGFIR chemotherapy cisplatin
ISSN号	1533-0346
DOI	http://dx.doi.org/10.1177/1533034615601281
URL标识	查看原文
收录类别	SCI(E) ; PUBMED
WOS记录号	WOS:000383212400005
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5188777
专题	河南大学
作者单位	1.[1]Department of Orthopedics, Huaihe Hospital of Henan University, Kaifeng, China hhyyly163@163.com. 2.[2]Department of Orthopedics, Huaihe Hospital of Henan University, Kaifeng, China. 3.[3]Department of Orthopedics, Huaihe Hospital of Henan University, Kaifeng, China. 4.[4]Department of Orthopedics, Huaihe Hospital of Henan University, Kaifeng, China. 5.[5]Department of Orthopedics, Huaihe Hospital of Henan University, Kaifeng, China. 6.[6]Department of Orthopedics, Huaihe Hospital of Henan University, Kaifeng, China. 7.[7]Department of Orthopedics, Huaihe Hospital of Henan University, Kaifeng, China.
推荐引用方式 GB/T 7714	Liu Yang[1],Zhu Shu-Tao[2],Wang Xiao[3],et al. MiR-100 Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion and Enhances Chemosensitivity by Targeting IGFIR[J]. TECHNOLOGY IN CANCER RESEARCH & TREATMENT,2016,15(5):NP40-NP48.
APA	Liu Yang[1].,Zhu Shu-Tao[2].,Wang Xiao[3].,Deng Jun[4].,Li Wei-Hua[5].,...&Liu Bing-Shan[7].(2016).MiR-100 Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion and Enhances Chemosensitivity by Targeting IGFIR.TECHNOLOGY IN CANCER RESEARCH & TREATMENT,15(5),NP40-NP48.
MLA	Liu Yang[1],et al."MiR-100 Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion and Enhances Chemosensitivity by Targeting IGFIR".TECHNOLOGY IN CANCER RESEARCH & TREATMENT 15.5(2016):NP40-NP48.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。